Jai Guruji Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth 1.45%
- Profit Growth 687.65%
- Ebitda -2635.31%
- Net Worth 38.26%
- Total Assets 53.89%
About Jai Guruji Bio Sciences
Jai Guruji Bio Sciences Private Limited (JGBSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 August 2020 (Four years and five months 29 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Arunima Sabharwal and Pammi Sabharwal serve as directors at the Company.
Company Details
-
Location
Gurugram, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85320HR2020PTC088292
-
Company No.
088292
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Aug 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Jai Guruji Bio Sciences Private Limited offer?
Jai Guruji Bio Sciences Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines.
Who are the key members and board of directors at Jai Guruji Bio Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arunima Sabharwal
|
Additional Director | 11-Sep-2021 | Current |
|
Pammi Sabharwal
|
Additional Director | 01-Nov-2021 | Current |
Financial Performance of Jai Guruji Bio Sciences.
Jai Guruji Bio Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.45% increase. The company also saw a substantial improvement in profitability, with a 687.65% increase in profit. The company's net worth Soared by an impressive increase of 38.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jai Guruji Bio Sciences?
Unlock access to Jai Guruji Bio Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Avid Health Solutions LlpArunima Sabharwal is a mutual person
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2024 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Jai Guruji Bio Sciences?
Jai Guruji Bio Sciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jai Guruji Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jai Guruji Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
